Evidence map›Paper›PMID 27005522›Full record

ArticleScientific reports2016

TFIIS.h, a new target of p53, regulates transcription efficiency of pro-apoptotic bax gene.

Jun-Ming Liao, Bo Cao, Jun Deng, Xiang Zhou, Michael Strong, Shelya Zeng, Jianping Xiong, Erik Flemington, Hua Lu

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. The ARTS of p53-dependent mitochondrial apoptosis.Journal of molecular cell biology · 2023
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Jun-Ming LiaoDepartment of Biochemistry &Molecular Biology and Cancer Center, Tulane University School of Medicine, 1430, Louisiana, LA 70112, USA.
Bo CaoDepartment of Biochemistry &Molecular Biology and Cancer Center, Tulane University School of Medicine, 1430, Louisiana, LA 70112, USA.
Jun DengDepartment of Biochemistry &Molecular Biology and Cancer Center, Tulane University School of Medicine, 1430, Louisiana, LA 70112, USA.
Xiang ZhouDepartment of Biochemistry &Molecular Biology and Cancer Center, Tulane University School of Medicine, 1430, Louisiana, LA 70112, USA.
Michael StrongDepartment of Pathology and Cancer Center, Tulane University School of Medicine, 1430, Louisiana, LA 70112, USA.
Shelya ZengDepartment of Biochemistry &Molecular Biology and Cancer Center, Tulane University School of Medicine, 1430, Louisiana, LA 70112, USA.
Jianping XiongDepartment of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang 330006, PR China.
Erik FlemingtonDepartment of Pathology and Cancer Center, Tulane University School of Medicine, 1430, Louisiana, LA 70112, USA.
Hua LuDepartment of Biochemistry &Molecular Biology and Cancer Center, Tulane University School of Medicine, 1430, Louisiana, LA 70112, USA.
Tulane University · USNanchang University · CN

Funding

The Role of Ribosomal Proteins in the P53-MDM2 PathwayR01CA095441 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI LU, HUA · 2002 to 2021
$5.1M
Role of the AMPK-MDMX-p53 pathway in cancerR01CA127724 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI LU, HUA · 2007 to 2019
$3.0M
Epstein Barr virus antisense transcriptionR01AI106676 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI FLEMINGTON, ERIK K · 2014 to 2018
$1.9M
Intercellular communication in Epstein Barr virus reactivationR01AI101046 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI FLEMINGTON, ERIK K · 2012 to 2016
$1.9M
Dual Targeting of the p53 pathway for development of anti-cancer therapyR01CA172468 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI LU, HUA · 2012 to 2016
$1.5M
Targeting GRP78 for p53 activation as anti-cancer therapyR21CA190775 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI LU, HUA · 2015 to 2016
$360k
Role of TFIIS.h in regulation of p53 responsive apoptosis and tumor suppressionR21CA201889 · NCI · TULANE UNIVERSITY OF LOUISIANA · PI LU, HUA · 2016 to 2017
$360k
NCI NIH HHS R01 CA095441NCI NIH HHS R01CA095441NCI NIH HHS R01 CA127724NCI NIH HHS R01CA127724NCI NIH HHS R01 CA172468NCI NIH HHS R01CA172468NCI NIH HHS R21 CA190775NCI NIH HHS R21CA190775NCI NIH HHS R21 CA201889NIAID NIH HHS R01 AI101046NIAID NIH HHS R01 AI106676
6 · The paper itself

Abstract

Tumor suppressor p53 transcriptionally regulates hundreds of genes involved in various cellular functions. However, the detailed mechanisms underlying the selection of p53 targets in response to different stresses are still elusive. Here, we identify TFIIS.h, a transcription elongation factor, as a new transcriptional target of p53, and also show that it can enhance the efficiency of transcription elongation of apoptosis-associated bax gene, but not cell cycle-associated p21 (CDKN1A) gene. TFIIS.h is revealed as a p53 target through microarray analysis of RNAs extracted from cells treated with or without inauhzin (INZ), a p53 activator, and further confirmed by RT-q-PCR, western blot, luciferase reporter, and ChIP assays. Interestingly, knocking down TFIIS.h impairs, but overexpressing TFIIS.h promotes, induction of bax, but not other p53 targets including p21, by p53 activation. In addition, overexpression of TFIIS.h induces cell death in a bax- dependent fashion. These findings reveal a mechanism by which p53 utilizes TFIIS.h to selectively promote the transcriptional elongation of the bax gene, upsurging cell death in response to severe DNA damage.

Indexed as

bcl-2-Associated X ProteinCell SurvivalDown-RegulationGene Expression Regulation, NeoplasticGene Knockdown TechniquesHCT116 CellsHumansIndolesOligonucleotide Array Sequence AnalysisPhenothiazinesPromoter Regions, GeneticStomach NeoplasmsTranscriptional Elongation FactorsTranscription, GeneticTumor Suppressor Protein p53BAX protein, humanbcl-2-Associated X ProteininauzhinIndolesPhenothiazinesTP53 protein, humanTranscriptional Elongation Factorstranscription factor S-IITumor Suppressor Protein p53

Identifiers

PMID27005522
PMCPMC4804275
OpenAlexW2304764549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.